Molecular Classification of Endometrial Cancer: Impact on Adjuvant Treatment Planning.

Active, not recruiting

• Conditions: Endometrial Cancer

• Registration Number: NCT06584630
• Lead Sponsor: Aristotle University Of Thessaloniki

Brief Summary

Molecular classification that has been recently incorporated in FIGO classification of endometrial cancer is a new triage tool for the better management of endometrial cancer patients.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2024-07-04
• Status Verified: 2024-09
• Study Start: 2024-09-01
• Study First Submitted QC: 2024-09-03
• Last Update Submitted: 2024-09-03
• Study First Posted: 2024-09-05
• Last Update Posted: 2024-09-05
• Primary Completion: 2024-12-31
• Study Completion: 2025-12-31

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

• Histological confirmation of endometrial cancer.
• Surgical treatment at our Gynecological - Oncology Unit.

Exclusion Criteria

• Refusal to be tested for the molecular classification
• Presence of a synchronous neoplasm.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Multidisciplinary Team Board decision change	2 years (study completion)	MDT decision for adjuvant treatment (Rate of adjuvant treatment change)

Trial Locations

Locations (1)

1st Department of Obstetrics & Gynecology, AUTh, "Papageorgiou" Hospital; 🇬🇷 Thessaloníki, Greece